Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • HyperFluor™ 594 Goat Anti-Rabbit IgG: Precision in Immunoflu

    2026-04-16

    HyperFluor™ 594 Goat Anti-Rabbit IgG: Precision in Immunofluorescence

    Principle and Setup: Elevating Immunodetection with Next-Generation Fluorophores

    Modern immunodetection hinges on the specificity, sensitivity, and multiplexing capacity of secondary antibodies. The HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody exemplifies best-in-class performance for fluorescence-based assays, powered by an affinity-purified goat polyclonal antibody targeting rabbit IgG heavy and light chains. Its robust conjugation to the HyperFluor™ 594 fluorophore (excitation 590 nm, emission 617 nm) ensures bright, photostable signals with minimal background, making it an optimal choice for applications such as immunocytochemistry (ICC/IF), immunohistochemistry (IHC), flow cytometry (FC), and ELISA (product_spec).

    Careful manufacturing by APExBIO, including antigen-coupled agarose purification, minimizes cross-reactivity and lot-to-lot variability. The formula’s inclusion of glycerol, BSA, and sodium azide protects protein structure and fluorophore integrity during shipment and storage. These features collectively support reproducible, high-fidelity immunodetection even in complex, multiplexed workflows (product_spec).

    Step-by-Step Workflow: Protocol Enhancements for Reliable Results

    To achieve optimal signal-to-noise ratios and data reproducibility, researchers should align their workflows with the antibody's validated parameters. Below, we outline critical steps and protocol recommendations for ICC/IF, IHC, and flow cytometry using the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody.

    Protocol Parameters

    • assay | dilution 1:500–1:2000 | ICC/IF | Maximizes signal while minimizing background for cell-based fluorescence imaging (product_spec)
    • assay | dilution 1:100–1:500 | IHC-P (paraffin) | Ensures robust tissue penetration and specific labeling of rabbit primaries in formalin-fixed paraffin-embedded sections (product_spec)
    • assay | dilution 1:250–1:1000 | Flow cytometry | Balances fluorescence intensity and minimizes non-specific binding in cell suspension assays (product_spec)
    • assay | incubation time 60 min at room temperature (RT) | ICC/IHC | Standard for efficient antibody-antigen binding without compromising epitope integrity | workflow_recommendation
    • assay | storage at -20°C, protect from light | all applications | Preserves antibody and fluorophore stability for up to 12 months (product_spec)

    For multiplexed detection, especially when combining multiple secondary antibodies from different host species, APExBIO recommends using pre-adsorbed versions to further reduce cross-reactivity (product_spec).

    Key Innovation from the Reference Study

    In the landmark study by Zhang et al. (reference_study), the integration of Mendelian randomization and eQTL analysis enabled the identification of ISG20 as a causal driver of atherosclerosis via macrophage-mediated lipid accumulation and inflammation. The research team leveraged immunofluorescence co-staining and IHC, using rabbit-derived primary antibodies, to spatially resolve ISG20 expression in atherosclerotic plaques. Notably, the study demonstrated significant upregulation of ISG20 in macrophage-rich and endothelial regions, validated by both Western blot and RT-qPCR (P < 0.01; source: reference_study).

    This experimental paradigm underscores the importance of high-specificity secondary detection reagents—such as the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody—for mapping protein targets in situ within pathologically relevant tissue. For translational cardiovascular studies, adopting such advanced secondary antibodies enables more precise validation of molecular mechanisms, as illustrated by the ISG20 findings.

    Comparative Advantages: Multiplexing and Quantitative Sensitivity

    Compared to conventional fluorescent secondary antibodies, the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) offers:

    • Superior photostability, supporting extended imaging sessions without rapid signal loss (product_spec).
    • Low cross-reactivity due to rigorous affinity purification, reducing off-target background and enabling clear signal discrimination in multiplexed panels (product_spec).
    • Consistent batch-to-batch performance, critical for longitudinal or multi-center studies.
    • Optimized emission (617 nm) for minimal spectral overlap with commonly used fluorophores such as FITC (em. 519 nm) and DAPI (em. 461 nm), facilitating complex multicolor workflows (product_spec).

    When benchmarked in immunocytochemistry and immunohistochemistry workflows, the antibody delivers robust signals even at high dilutions, translating to lower reagent consumption and cost efficiency (source: product_spec).

    Troubleshooting and Optimization: Ensuring Reproducible Performance

    Despite its robust design, achieving optimal results with the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody requires attention to detail in protocol execution. Key troubleshooting and optimization strategies include:

    • Minimize freeze-thaw cycles: Aliquot antibody upon first receipt and store at -20°C to prevent degradation (source: product_spec).
    • Protect from light: Exposure to light can degrade the HyperFluor™ 594 fluorophore, reducing signal intensity. Always handle and store antibody solutions and stained samples in the dark (product_spec).
    • Optimize washing steps: Insufficient washing can increase background, while excessive washing may elute weakly bound antibodies, compromising sensitivity. Titrate washing buffer composition and duration based on pilot experiments (workflow_recommendation).
    • Use appropriate blocking reagents: For high-background tissues (e.g., spleen, liver), add 5% normal goat serum or BSA during blocking steps to reduce non-specific binding (workflow_recommendation).
    • Validate multiplex panels: When designing multiplexed assays, confirm that secondary antibodies do not cross-react with primary antibodies from other species by performing single-stain and secondary-only controls (workflow_recommendation).

    Interlinking the Evidence: Positioning Within the Scientific Landscape

    The technological advances of the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody are complemented and contextualized by several recent resources:

    • Illuminating Molecular Pathways in Atherosclerosis—Extends the discussion on multiplexed immunofluorescence for cardiovascular research, underscoring the importance of advanced secondary antibodies in mechanistic discovery. This aligns with the application of the HyperFluor™ 594 reagent in ISG20 localization.
    • Elevating Immune Target Validation—Highlights the antibody’s pivotal role in immune target validation, particularly in studies integrating novel targets like ISG20 and CLEC5A, and provides best practices for multiplexed assays.
    • Advanced Fluorescence Detection—Details the product’s performance in ultra-sensitive detection settings, complementing the data-driven benefits discussed throughout this article.

    Future Outlook: Enabling Deeper Insights in Translational Immunology

    As demonstrated in the reference study by Zhang et al., the convergence of high-specificity reagents and advanced genetic analysis tools empowers researchers to clarify causative molecular mechanisms in complex diseases like atherosclerosis (reference_study). The continued evolution of secondary antibodies—exemplified by the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L)—will be crucial for unraveling spatial and cellular heterogeneity in disease, supporting the identification and validation of new biomarkers and therapeutic targets.

    With the robust support of APExBIO’s quality standards and innovative conjugation technologies, researchers are well-positioned to achieve reproducible, multiplexed, and quantitative immunodetection—driving breakthroughs across immunology, cell biology, and pathology in years to come.